Addus HomeCare (ADUS) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

Employees

Data from SEC filings

CEO pay ratio

CEO Salary

Median Employee Salary

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Carbon Climate Climate Change Environment Environmental Environmental Protection Greenhouse Gas Emission Intensity Materials Nature Ocean Offset Package Pandemic Waste Access African American Asian Attrition Benefits Black Citizenship Collective Bargaining Community Community Engagement Culture Customer Cyber Cybersecurity Data Security Death Demographic Demographics Disability Diversity Employee Employee Engagement Employee Retention Engagement Ethnicity Gender Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Capital Human Resources Incident Injuries Injury Latinx LGBTQ License to Operate Living Wage Minimum Wage Minority OSHA Pay Equity Perquisites Privacy Recruit Recruitment Reimbursement Resource Group Retention Retirement Safety Satisfaction Skilled Skills Social Societal Stakeholder Supplier Supply Chain Talent Training Union Unionized Volunteer Women Workers Workforce Action Plan Assessment Assurance Audit Bonus Chronic Classified Claw Back Commitment Conflict of Interest Corporate Governance Corruption Department of ESG Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Innovation Innovative Investigation Key Performance Indicator Lawsuit Leadership Litigation Long-term Majority Mission Other Public Company Boards Oversee Oversight Perquisite Pledging Purpose Reputation Reputational Responsibility Responsible Shareholder Proposals Special Meeting Strategy Sustainability Sustainable Targets Tax Tenure Transparency

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

Addus HomeCare Corporation (the “Company”) held its 2022 annual meeting of shareholders (the “Annual Meeting”) on June 15, 2022. At the Annual Meeting, a total of 15,056,019 shares of the Company’s common stock, out of a total of 16,071,408 shares of common stock outstanding and entitled to vote, were present in person or represented by proxies. The Company’s shareholders (i) elected Esteban Lopez, M.D., Jean Rush and Susan T. Weaver, M.D., FACP, to serve as Class I directors for terms expiring at the 2025 annual meeting of the Company’s shareholders; (ii) ratified the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as the Company’s independent auditor for fiscal year 2022; and (iii) approved on an advisory, non-binding basis, the Company’s compensation of its named executive officers as set forth in the proxy statement filed on April 27, 2022 (the “Proxy Statement”). The votes on these matters were as follows:

(1)	The election of Esteban Lopez, M.D., Jean Rush and Susan T. Weaver, M.D., FACP, to serve as Class I directors for a term expiring at the 2025 annual meeting of the shareholders of the Company:

Name	For	Withhold Authority	Broker Non-Votes

(a) Esteban Lopez, M.D.	13,028,141	1,666,921	360,957
(b) Jean Rush	14,104,725	590,337	360,957
(c) Susan T. Weaver, M.D., FACP	14,069,002	626,060	360,957

(2)	The ratification of the appointment of PricewaterhouseCoopersLLP, an independent registered public accounting firm, as the Company’s independent auditor for the fiscal year ending December 31, 2022:

For		Against		Abstain		Broker Non-Votes

15,052,081		1,811		2,127		—

(3)	The approval, on an advisory, non-binding basis, of the Company’s compensation of its named executive officers as set forth in the Proxy Statement:

For		Against		Abstain		Broker Non-Votes

13,595,613		1,089,462		9,987		360,957